24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]

RxCUI: 2743035
RxNorm name: 24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Display name: 24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Full name: 24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JAKAFI	RUXOLITINIB	Incyte Corporation	f1c82580-87ae-11e0-bc84-0002a5d5c51b	2026-07-20	Warnings, Adverse reactions	Exact identifier rxcui: 2743035

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f1c82580-87ae-11e0-bc84-0002a5d5c51b	Jakafi XR 44 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi] [SBD] · Jakafi XR 44 MG 24 HR Extended Release Oral Tablet [SY]	3	40	These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 2011	20260501